Clorox (NYSE:CLX – Get Rating) had its price objective raised by Wells Fargo & Company from $120.00 to $130.00 in a research note published on Tuesday morning, The Fly reports. The firm currently has an underweight rating on the stock.
CLX has been the subject of several other reports. DA Davidson upped their price objective on shares of Clorox from $123.00 to $124.00 and gave the stock a neutral rating in a report on Friday, August 12th. Credit Suisse Group decreased their price target on shares of Clorox from $140.00 to $130.00 and set an underperform rating for the company in a research note on Thursday, August 4th. Raymond James assumed coverage on shares of Clorox in a research note on Tuesday, July 12th. They issued an outperform rating and a $160.00 price target for the company. Barclays increased their price target on shares of Clorox from $93.00 to $101.00 and gave the stock an underweight rating in a research note on Friday, August 19th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of Clorox from $145.00 to $132.00 and set a hold rating for the company in a research note on Tuesday, June 21st. Nine analysts have rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of Reduce and an average price target of $130.67.
Clorox Stock Down 2.7 %
Shares of NYSE CLX opened at $144.00 on Tuesday. The company has a current ratio of 0.97, a quick ratio of 0.54 and a debt-to-equity ratio of 3.39. Clorox has a 12 month low of $120.50 and a 12 month high of $186.86. The firm has a market capitalization of $17.74 billion, a PE ratio of 38.71, a price-to-earnings-growth ratio of 5.28 and a beta of 0.18. The firm has a fifty day simple moving average of $145.65 and a two-hundred day simple moving average of $142.83.
Clorox Increases Dividend
Institutional Trading of Clorox
A number of institutional investors have recently made changes to their positions in CLX. Lazard Asset Management LLC boosted its holdings in shares of Clorox by 55.0% during the 4th quarter. Lazard Asset Management LLC now owns 369 shares of the company’s stock valued at $64,000 after acquiring an additional 131 shares during the last quarter. Covestor Ltd purchased a new position in shares of Clorox in the fourth quarter worth approximately $94,000. Candriam Luxembourg S.C.A. boosted its holdings in shares of Clorox by 20.1% in the fourth quarter. Candriam Luxembourg S.C.A. now owns 15,156 shares of the company’s stock worth $2,643,000 after buying an additional 2,533 shares during the last quarter. Donoghue Forlines LLC purchased a new position in shares of Clorox in the fourth quarter worth approximately $630,000. Finally, Bank of Montreal Can boosted its holdings in shares of Clorox by 7.0% in the fourth quarter. Bank of Montreal Can now owns 307,160 shares of the company’s stock worth $52,981,000 after buying an additional 20,194 shares during the last quarter. Hedge funds and other institutional investors own 81.69% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States.
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- Is Five Below Trying to Punch Too High?
- These 3 Reports Will Tell Us Much About the Current Economy
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle’s FQ1 Report
- Three Value Stocks For A Volatile Market
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.